Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

19 Sep 2012 07:00

RNS Number : 5733M
Standard Life Euro Pri Eqty Tst PLC
19 September 2012
 



 

Standard Life European Private Equity Trust PLC

 

Investment update for the quarter ended 30 June 2012

 

·; NAV fell by 1.3% to 232.1p for the quarter ended 30 June 2012

·; NAV total return was up 2.0% for the first nine months of the current financial year starting 1 October 2011

·; Realised gains and income during the quarter were £6.2million (1.6% of NAV). The unrealised loss on the portfolio on a constant exchange rate basis was £1.6 million (0.4% of NAV); in addition, there was an unrealised foreign exchange loss of £8.7 million (2.3% of NAV).

·; 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2012

·; Outstanding commitments were £136.0 million at 18 September 2012

·; Net cash was £8.5 million at 18 September 2012

 

For the quarter ended 30 June 2012 the Company's net asset value per ordinary share ("NAV") fell by 1.3% to 232.1p (diluted - 229.3p), from 235.2p (diluted - 232.3p) at 31 March 2012. At 30 June 2012 the Company's net assets were £377.0 million (31 March 2012 - £381.9 million).

 

New transactional activity remained subdued in the European private equity market in the second quarter of 2012, due to the impact of the difficult macro-economic and political environment in Europe and constraints on debt availability for leveraged transactions. A total of €13.7 billion of transactions by enterprise value was reported during the quarter, which was slightly higher than the first quarter of 2012, but compared to a value of €30.6 billion in the second quarter of 2011. Notwithstanding, the Manager continued to see exit activity across the Company's portfolio as private equity managers focused on selling investee companies, particularly to corporate buyers.

 

The closing value of the Company's portfolio of 37 private equity fund interests was £388.4 million at 30 June 2012 (31 March 2012 - £396.0 million). The total unrealised loss for the quarter ended 30 June 2012 was £10.3 million, of which £1.6 million was an unrealised loss on a constant exchange rate basis and £8.7 million was an unrealised foreign exchange loss. The £1.6 million fall in the value of the portfolio on a constant exchange rate basis reflected weaker listed equity markets, partially offset by positive earnings growth at many underlying portfolio companies. The FTSE All-Share Index and the MSCI Europe Index (in euros) fell by 3.7% and 4.6% respectively during the quarter. The unrealised foreign exchange loss was driven by the euro depreciating by 3.0% relative to sterling over the quarter.

 

During the period the Company funded £8.1 million of draw downs (six months ended 31 March 2012 - £16.1 million) and received £11.5 million of distributions (six months ended 31 March 2012 - £33.4 million). The distributions received generated £6.2 million of realised gains and income, which was equivalent to a return of 2.2 times the acquisition cost of the realised investments.

 

The Company had total outstanding commitments to its 37 private equity fund interests of £122.8 million at 30 June 2012 (31 March 2012 - £133.9 million).

 

At 30 June 2012 the Company had net indebtedness of £11.8 million (31 March 2012 - net indebtedness of £14.4 million).

 

During the period from 30 June 2012 to 18 September 2012 the Company funded £10.1 million of draw downs and received £31.1 million of distributions. On 4 September 2012 the Company made a new fund commitment, with a €30 million commitment to Equistone Partners Europe Fund IV. The Company has existing commitments to Equistone Partners Europe Funds I, II and III. Accordingly, at 18 September 2012 the Company's total outstanding commitments and net cash balance were £136.0 million and £8.5 million respectively.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2012 on or around 3 December 2012.

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEVLFFLKFEBBV
Date   Source Headline
12th Feb 20217:00 amRNSEstimated NAV at 31 January 2021
5th Feb 202112:17 pmRNSDoc re. Annual Report
2nd Feb 20215:28 pmRNSDirector/PDMR Shareholding
26th Jan 20217:05 amRNSEstimated NAV at 31 December 2020
26th Jan 20217:00 amRNSAnnual Financial Report
5th Jan 20214:00 pmRNSQuarterly disclosure
22nd Dec 20204:30 pmRNSREPLACEMENT: Dividend Declaration
14th Dec 20203:01 pmRNSEstimated NAV at 30 November
14th Dec 20203:01 pmRNSFourth Interim Dividend
13th Nov 20207:00 amRNSEstimated NAV at 31 October 2020
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
5th Nov 20208:31 amRNSEdison review on Standard Life Private Equity Trst
3rd Nov 202012:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:02 amRNSDirector Declaration
14th Oct 20207:00 amRNSEstimated NAV at 30 September 2020
2nd Oct 20204:28 pmRNSQuarterly disclosure
30th Sep 20207:02 amRNSEstimate Net Asset Value at 31 August 2020
30th Sep 20207:00 amRNSQuarterly Investment Update at 30 June 2020
24th Sep 20207:00 amRNSIncrease of Loan Facility
8th Sep 202012:21 pmRNSEdison review on Standard Life Private Equity Trst
3rd Sep 202011:08 amRNSThird Interim Dividend
14th Aug 20207:00 amRNSEstimated NAV at 31 July 2020
13th Aug 202010:20 amRNSDirector/PDMR Shareholding
6th Aug 20203:04 pmRNSDirector/PDMR Shareholding
15th Jul 20202:10 pmRNSUpdate research from QuotedData
14th Jul 20207:00 amRNSEstimated NAV at 30 June 2020
2nd Jul 20204:43 pmRNSQuarterly disclosure
26th Jun 20207:00 amRNSHalf-Yearly Report
18th Jun 20207:05 amRNSEstimated NAV at 31 May 2020
18th Jun 20207:00 amRNSHalf-year Report
15th May 20207:00 amRNSEstimated Net Asset Value at 30 April 2020
12th May 20204:07 pmRNSHolding(s) in Company
11th May 202012:14 pmRNSGlobal Macro Review – May 2020
28th Apr 20204:20 pmRNSDisclosure of Rights Attaching to Equity Shares
28th Apr 20203:35 pmRNSDirector/PDMR Shareholding
28th Apr 202011:52 amRNSDirector/PDMR Shareholding
24th Apr 20207:02 amRNSEstimated Net Asset Value at 31 March 2020
24th Apr 20207:00 amRNSQuarterly Investment Update at 31 December 2019
3rd Apr 202010:22 amRNSQuarterly Disclosure
13th Mar 20207:00 amRNSMonth End Net Asset Value(s)
11th Mar 20201:59 pmRNSReal Estate Roundup Review – March 2020
9th Mar 20209:52 amRNSDirector Declaration
9th Mar 20207:00 amRNSFirst Interim Dividend
24th Feb 20203:20 pmRNSResult of AGM
14th Feb 20207:00 amRNSMonth End Net Asset Value(s)
13th Feb 202012:37 pmRNSReplacement - Director/PDMR Shareholding
13th Feb 202012:16 pmRNSDirector/PDMR Shareholding
12th Feb 20202:55 pmRNSDirector/PDMR Shareholding
29th Jan 20208:13 amRNSEdison review on Standard Life Private Equity
28th Jan 20204:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.